中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
MeSH:(Antibiotics, Antitubercular/*adverse effects)

1.A Case of Pseudomembranous Colitis Associated with Rifampin.

Ji Young PARK ; Joon Seok KIM ; Sun Jong JEUNG ; Myung Sook KIM ; Seok Chan KIM

The Korean Journal of Internal Medicine 2004;19(4):261-265

2.A Case of Rifampicin associated Pseudomembranous Colitis.

Jae Hi KIM ; Jin Hyung PARK

The Korean Journal of Gastroenterology 2004;43(6):376-379

4.Rifampicin-Induced Minimal Change Disease Is Improved after Cessation of Rifampicin without Steroid Therapy.

Dong Hyuk PARK ; Sul A LEE ; Hyeon Joo JEONG ; Tae Hyun YOO ; Shin Wook KANG ; Hyung Jung OH

Yonsei Medical Journal 2015;56(2):582-585

5.A Case of Pseudomembranous Colitis Associated with Rifampicin Therapy in a Patient with Rectal Cancer and Gastrointestinal Tuberculosis.

Yong Jun CHOI ; Hyung Gil KIM ; Yun Ah CHOI ; Woo Chul JOO ; Dong Wook SON ; Chul Hyun KIM ; Yong Woon SHIN ; Young Soo KIM

The Korean Journal of Gastroenterology 2009;53(1):53-56

6.Metabonomic profile of urine from rats administrated with different treatment period of rifampin.

Yan LIAO ; Shuang-Qing PENG ; Xian-Zhong YAN ; He-Bing CHEN ; Li-Shi ZHANG

Acta Academiae Medicinae Sinicae 2008;30(6):696-702

7.Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication.

Yu Mi LEE ; Kyu Chan HUH ; Soon Man YOON ; Byung Ik JANG ; Jeong Eun SHIN ; Hoon Sup KOO ; Yunho JUNG ; Sae Hee KIM ; Hee Seok MOON ; Seung Woo LEE

Gut and Liver 2016;10(2):250-254

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO